机构:[a]Department of Urology, Tangshan Gongren Hospital, Tangshan, China[b]Department of Pathology, Hospital of Heilongjiang Province, Harbin, China[c]Department of Internal Medicine, Tumor Hospital of Qingdao City, Qingdao, China[d]Department of Nephrology, First Affiliated Hospital, Kunming Medical University, Kunming, China内科科室肾脏内科昆明医科大学附属第一医院
第一作者机构:[a]Department of Urology, Tangshan Gongren Hospital, Tangshan, China
通讯作者:
推荐引用方式(GB/T 7714):
Yan C.-Q,Lu Y.-H,Tang S.-M,et al.MiR-519d inhibits prostate cancer cell proliferation, cycle and invasion via targeting NRBP1[J].European Review for Medical and Pharmacological Sciences.2018,22(10):
APA:
Yan, C.-Q,Lu, Y.-H,Tang, S.-M&Fan, W.-X.(2018).MiR-519d inhibits prostate cancer cell proliferation, cycle and invasion via targeting NRBP1.European Review for Medical and Pharmacological Sciences,22,(10)
MLA:
Yan, C.-Q,et al."MiR-519d inhibits prostate cancer cell proliferation, cycle and invasion via targeting NRBP1".European Review for Medical and Pharmacological Sciences 22..10(2018)